Webcast InSite Vision Incorporated at Roth Conference (Replay) 03/20/13 at 12:00 p.m. PT
Webcast Q1 2013 InSite Vision Incorporated Earnings Conference Call (Replay) 05/07/13 at 4:30 p.m. ET
InSite Vision is committed to advancing new and superior ophthalmologic products for unmet eye care needs. The Company's lead product is AzaSite*, which targets infections of the eye. AzaSite contains the drug azithromycin, a broad-spectrum antibiotic formulated with DuraSite, InSite Vision's patented drug-delivery vehicle, which offers the benefit of a low-dosing regimen, attractive to both the eye-care pati...
Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.